Michael Gold

Summary

Affiliation: University of Adelaide
Country: Australia

Publications

  1. ncbi A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol
    Jesia G Berry
    Discipline of Public Health, The University of Adelaide, Adelaide, South Australia
    Trials 12:1. 2011
  2. ncbi Use of the Australian Childhood Immunisation Register for vaccine safety data linkage
    Michael Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia, Australia
    Vaccine 28:4308-11. 2010
  3. ncbi Atopic disease in childhood
    Michael S Gold
    Department of Paediatrics, Adelaide University, Women s and Children s Hospital, North Adelaide, Adelaide, SA 5000, Australia
    Med J Aust 182:298-304. 2005
  4. ncbi Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study
    Michael S Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia, Australia
    Vaccine 28:4487-98. 2010
  5. ncbi Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
    Michael S Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, SA 5001, Australia
    Sex Health 7:320-4. 2010
  6. ncbi Local reactions after the fourth dose of acellular pertussis vaccine in South Australia
    Michael S Gold
    Adelaide University Department of Paediatrics, Women s and Children s Hospital, 75 King William Road, Adelaide, SA 5000, Australia
    Med J Aust 179:191-4. 2003
  7. ncbi EpiPen epidemic or good clinical practice?
    M S Gold
    Adelaide University Department of Paediatrics and Anaphylaxis Working Party, Australasian Society of Clinical Immunology and Allergy Sydney, New South Wales Australia
    J Paediatr Child Health 39:376-7. 2003
  8. ncbi Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern?
    Michael S Gold
    University Department of Paediatrics, and Immunisation Coordination Unit, Adelaide, Australia
    Drug Saf 25:85-90. 2002
  9. ncbi Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines
    C A Boros
    Department of Paediatrics, University of Adelaide, Women s and Children s Hospital, 72 King William Road, SA 5006, North Adelaide, Australia
    Vaccine 19:3537-42. 2001
  10. ncbi Parent reported allergy and anaphylaxis in 4173 South Australian children
    C A Boros
    University of Adelaide Department of Paediatrics, Women s and Children s Hospital, Australia
    J Paediatr Child Health 36:36-40. 2000

Collaborators

  • Peter McIntyre
  • C A Boros
  • Adriana Parrella
  • Maureen Watson
  • Charles S Hii
  • A James Martin
  • Andrew S Kemp
  • J Declan Kennedy
  • Richard J Woodman
  • D M Roberton
  • Margarette Kolczak
  • U Heininger
  • Simon G A Brown
  • Raymond J Mullins
  • R L Davis
  • Vitali Pool
  • N A Halsey
  • Jan Bonhoeffer
  • Patrick Quinn
  • Bernadette Boog
  • Jesia G Berry
  • Peter Richmond
  • Jim Buttery
  • Danny Camfferman
  • Jens U Ruggeberg
  • Glenda L Lawrence
  • D J Palmer
  • John Menkes
  • Patricia Vermeer
  • Glacus de Souza-Brito
  • Sharon Choo
  • Alex Quach
  • Maurizio Costabile
  • Grant Booker
  • Harmeet Singh
  • Antonio Ferrante
  • Joanne Smart
  • Helen Marshall
  • Bernadette Richards
  • Jillian White
  • Colin Thomson
  • Philip Ryan
  • Su San Lee
  • Jane Freemantle
  • Katherine M Duszynski
  • Julie Leask
  • Gary Lacey
  • Elizabeth Elliot
  • Jenny Royle
  • Nick Wood
  • John McNeil
  • Elizabeth Roughead
  • Vicki Xafis
  • Heather Petty
  • Tony Woollacott
  • Annette J Braunack-Mayer
  • Lee Taylor
  • Rebecca Horgan
  • Sean Tarrant
  • Rod Givney
  • Glenda Lawrence
  • Kurt Lushington
  • Peter Winwood
  • Babatunde Imoukhuede
  • Nick Simpson
  • Jose Maria Bayas
  • Ian Boyd
  • Ali Khamesipour
  • Michael D Blum
  • Glacus de Souza Brito
  • Michel Erlewyn-Lajeunesse
  • Sheila Friedlander
  • Susana Martin
  • Padmasiri E Aratchige
  • Patricia Nell
  • Mika Makela
  • M Makrides
  • Scott Halperin
  • Najwa Khuri-Bulos
  • Hanne Nokleby
  • Dean Blumberg
  • Harald Heijbel
  • Miles Braun
  • Margaret C Fisher

Detail Information

Publications21

  1. ncbi A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol
    Jesia G Berry
    Discipline of Public Health, The University of Adelaide, Adelaide, South Australia
    Trials 12:1. 2011
    ..This paper describes the rationale for the trial and provides an overview of the design and methods...
  2. ncbi Use of the Australian Childhood Immunisation Register for vaccine safety data linkage
    Michael Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia, Australia
    Vaccine 28:4308-11. 2010
    ..This study confirms the known association between MMR vaccination and febrile convulsions and in doing so demonstrates the feasibility of using the ACIR for data linkage and vaccine safety surveillance...
  3. ncbi Atopic disease in childhood
    Michael S Gold
    Department of Paediatrics, Adelaide University, Women s and Children s Hospital, North Adelaide, Adelaide, SA 5000, Australia
    Med J Aust 182:298-304. 2005
    ..Preventing atopic disease in high-risk infants and hindering progression of disease in children with established disease are the areas of active research...
  4. ncbi Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study
    Michael S Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia, Australia
    Vaccine 28:4487-98. 2010
    ..If used, these resources could improve the quality of adverse event reports which would facilitate the application of the BC case definition at a regional and/or national level...
  5. ncbi Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
    Michael S Gold
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, SA 5001, Australia
    Sex Health 7:320-4. 2010
    ..Case series of more uncommon and serious AEFI, both known to be potentially vaccine related (anaphylaxis, conversion disorders and lipoatrophy) and otherwise (multiple sclerosis and pancreatitis) have been published...
  6. ncbi Local reactions after the fourth dose of acellular pertussis vaccine in South Australia
    Michael S Gold
    Adelaide University Department of Paediatrics, Women s and Children s Hospital, 75 King William Road, Adelaide, SA 5000, Australia
    Med J Aust 179:191-4. 2003
    ....
  7. ncbi EpiPen epidemic or good clinical practice?
    M S Gold
    Adelaide University Department of Paediatrics and Anaphylaxis Working Party, Australasian Society of Clinical Immunology and Allergy Sydney, New South Wales Australia
    J Paediatr Child Health 39:376-7. 2003
  8. ncbi Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern?
    Michael S Gold
    University Department of Paediatrics, and Immunisation Coordination Unit, Adelaide, Australia
    Drug Saf 25:85-90. 2002
    ..The benefits of pertussis vaccination still outweigh the risk and universal childhood pertussis vaccination should continue to be advocated...
  9. ncbi Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines
    C A Boros
    Department of Paediatrics, University of Adelaide, Women s and Children s Hospital, 72 King William Road, SA 5006, North Adelaide, Australia
    Vaccine 19:3537-42. 2001
    ..Storage of pertussis vaccines below 0 degree C appears to alter the immunogenicity of PRN and FHA. Further study is required to determine the effects of such storage on vaccine protective efficacy...
  10. ncbi Parent reported allergy and anaphylaxis in 4173 South Australian children
    C A Boros
    University of Adelaide Department of Paediatrics, Women s and Children s Hospital, Australia
    J Paediatr Child Health 36:36-40. 2000
    ..To determine the prevalence of parent reported allergy and anaphylaxis in a sample of children and to investigate the first aid management of anaphylaxis in the schools and preschools that these children attend...
  11. ncbi Electronic temperature monitoring and feedback to correct adverse vaccine storage in general practice
    M S Gold
    University Department of Paediatrics, Women s and Children s Hospital, Adelaide, SA
    Med J Aust 171:83-4. 1999
    ....
  12. ncbi Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010
    Adriana Parrella
    Disciplines of Paediatrics and Public Health, School of Paediatrics and Reproductive Health, School of Population Health and Clinical Practice, University of Adelaide, Adelaide, SA, Australia
    Hum Vaccin Immunother 8:662-7. 2012
    ..Addressing influenza vaccine safety concerns to promote influenza vaccination in the community is required...
  13. ncbi Eczema, sleep, and behavior in children
    Danny Camfferman
    Discipline of Paediatrics, School of Paediatrics and Reproductive Health, University of Adelaide, South Australia, Australia
    J Clin Sleep Med 6:581-8. 2010
    ..It is unclear if sleep disruption in children with eczema has similar effects particularly after controlling for known comorbid disorders such as asthma and rhinitis...
  14. ncbi Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old
    Patrick Quinn
    Discipline of Paediatrics, Women s and Children s Hospital, Part of the Children, Youth and Women s Health Service, South Australia, Australia
    Vaccine 29:4230-7. 2011
    ....
  15. ncbi Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91(phox) resulting in the rare X91(+) variant of chronic granulomatous disease
    Bernadette Boog
    Department of Immunopathology, SA Pathology at Women s and Children s Hospital, North Adelaide, South Australia
    Hum Mutat 33:471-5. 2012
    ..These mutations and the effect of glutathione provide a unique insight into disease pathogenesis and potential therapy in variant X91(+)-CGD...
  16. ncbi Effect of cooked and raw egg consumption on ovalbumin content of human milk: a randomized, double-blind, cross-over trial
    D J Palmer
    Child Health Research Institute, Women's and Children's Hospital, North Adelaide, SA, Australia
    Clin Exp Allergy 35:173-8. 2005
    ..A dose-response correlation was indicated. As excretion of OVA in human milk appears to be a normal phenomenon, further studies need to determine the threshold of OVA excretion that leads to symptoms in egg-allergic breastfed infants...
  17. ncbi Anaphylaxis: diagnosis and management
    Simon G A Brown
    University of Western Australia, Fremantle Hospital, Fremantle, WA, Australia
    Med J Aust 185:283-9. 2006
    ..Provision of a MedicAlert bracelet should also be arranged...
  18. ncbi Annual report on surveillance of adverse events following immunisation in Australia, 2006
    Glenda L Lawrence
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, The Children s Hospital at Westmead, New South Wales
    Commun Dis Intell 31:269-82. 2007
    ..The data confirm the low rate of AEFI reported in Australia and demonstrate the ability of the system to detect and investigate signals such as those associated with changes in immunisation programs...
  19. ncbi Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
    Jan Bonhoeffer
    University Children's Hospital, PO Box, 4005 Basle, Switzerland
    Vaccine 22:557-62. 2004
  20. ncbi Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
    Jan Bonhoeffer
    University Children's Hospital, Basle, Switzerland
    Vaccine 22:563-8. 2004
  21. ncbi Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
    Jens U Ruggeberg
    Pädiatrische Infektiologie, Universitätskinderklinik Düsseldorf, Germany
    Vaccine 25:5675-84. 2007